The Home of the Life Sciences Industry
Explore Latest News
- Sesen Bio Shares Plunge Despite Reporting Positive Interim Phase III Results
- Crowdsource Funding to Launch a Biotech: Is it as Crazy as it Sounds?
- Approved! FDA gives Dova Pharma’s Doptelet a Thumbs Up
- Celgene’s Deal Boss Golumbeski Made a Quiet Exit in April
- Allergan Draws on Another Aptinyx Compound to Complement its Phase III Depression Drug